Business
New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause Of Morbidity And Mortality Projected To Grow In The United States
New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause O...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"\n \n \n \n New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause Of Morbidity And Mortality Projected To Grow In The United States\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnbcc{\nBORDER-TOP-COLOR:; BORDER-COLLAPSE: COLLAPSE; BORDER-LEFT-COLOR:; BORDER-BOTTOM-COLOR:; BORDER-RIGHT-COLOR:\n}\n \n \n \n \n \n \n PR Newswire\n \n \n \n \n \n Salix Pharmaceuticals' First\n \n \n \n Liver Health Annual Trends Report\n \n \n \n \n \n \n \n Highlights Urgent Need for Evidence-Based Guidelines to be Adopted by Physicians\n \n \n \n \n LAVAL, Quebec\n \n ,\n \n Oct. 25, 2021\n \n /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) (\"Bausch Health\") and its gastroenterology (GI) business, Salix Pharmaceuticals (\"Salix\"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal and liver diseases, today released key findings from a survey of health care providers (HCP) treating chronic liver disease (CLD), including potential gaps in prevention and diagnosis efforts. The\n \n Liver Health Annual Trends Report\n \n , which surveyed 100 physicians active in the management and treatment of CLD, offers facts and trends about CLD in America, a disease that affects an estimated 4.5 million adults in\n \n the United States\n \n .\n \n 1\n \n \n \n Research indicates that more people aged 25-54 die from CLD and cirrhosis than diabetes or stroke.\n \n 2\n \n The results of this survey and in-depth interviews of physicians suggest CLD has not received the attention or level of effort needed for adequate prevention, diagnosis, and standardization of its management. This report is designed to shed light on the often asymptomatic disease,\n \n 3\n \n which can lead to a host of other serious issues including cirrhosis or hepatic encephalopathy (HE).\n \n \n \"Salix is committed to helping HCPs addre...